Achilles Therapeutics (ACHL)
NASDAQ: ACHL
· Real-Time Price · USD
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM
Achilles Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.38K | -12.27M | -18.79M | -16.59M | -16.85K | -17.51M | -24.24M | -12.37M | -17.29M | -17.36M | -18.23M | -12.95M | -16.16M | -13.77M |
Depreciation & Amortization | 1.18M | 1.18M | 1.16M | 1.2M | 1.25K | 1.11M | 837.23K | 892.33K | 916K | 1.05M | 837K | 832K | 830K | 789K |
Stock-Based Compensation | 1.31M | 1.39M | 1.4M | 1.61K | 1.7K | 1.65M | 1.69M | 1.65M | 1.72M | 1.96M | 1.76M | 1.73M | 1.44M | 1.38M |
Other Working Capital | -3.04K | -7.8M | 2.15M | 14.89M | -2.56K | 65K | -2.08M | 5.49M | -4.98M | -6.34M | 22K | 5.12M | -8.94M | -1.56M |
Other Non-Cash Items | -19.8M | 3.75M | 3.72M | 3.97M | -954 | -122K | 10.1M | 3.45M | 440K | -376K | -137K | -295K | -113K | 527K |
Deferred Income Tax | n/a | n/a | -3.71M | -2.4M | n/a | n/a | -3.36M | -3.43M | n/a | n/a | 155K | 4K | n/a | n/a |
Change in Working Capital | -3.04K | -7.8M | 2.01M | 14.89M | -2.56K | -3M | -4.74M | 6.85M | -2.2M | -5.92M | 1.32M | 1.58M | -4.67M | -6.16M |
Operating Cash Flow | -17.33M | -17.5M | -14.23M | 1.07M | -17.41K | -17.85M | -19.72M | -2.96M | -16.41M | -20.64M | -14.29M | -9.1M | -18.68M | -17.22M |
Capital Expenditures | -36 | -694.6K | -45.61K | -61.38K | -537 | -454K | -2.07M | -1.86M | -1.74M | -1.86M | -2M | -1.22M | -2.04M | -2.38M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -35.96K | n/a | n/a | n/a | n/a | n/a | -7.51M | n/a | n/a | n/a | -7.63M | n/a | n/a | n/a |
Investing Cash Flow | -36K | -694.6K | -45.61K | -61.38K | -537 | -454K | -2.07M | -1.86M | -1.74M | -1.86M | -2M | -1.22M | -2.04M | -2.38M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 2.86 | n/a | n/a | n/a | 1K | n/a | 10.29 | n/a | n/a | 60K | n/a | 161.61M | -914K |
Financial Cash Flow | 4.42 | 5K | -4.86 | 8.03K | n/a | n/a | 9.67 | 989.71 | n/a | n/a | -389.58K | 60.00 | 161.61K | -914 |
Net Cash Flow | -17.19M | -19.22M | -8.6M | -3.57M | -14.75K | -14.88M | -6.55M | -21.7M | -35.34M | -29.39M | -15.56M | -17.41M | 140.06M | -18.59M |
Free Cash Flow | -17.34K | -18.19M | -14.27M | 1.01M | -17.95K | -18.31M | -21.79M | -4.83M | -18.14M | -22.5M | -16.29M | -10.32M | -20.71M | -19.6M |